Monthly Communication Reports in:
October
2022
Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.
The list below is sorted by communication date, beginning with the most recent.
Boehringer Ingelheim Canada Ltd.
Andrea
Sambati,
President, CEO
(Corporation)
-
Boehringer Ingelheim Canada Ltd.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Michelle Boudreau,
Executive Director, Office of Pharmaceutical Management Strategies
|
Health Canada (HC)
-
Michelle Mujoomdar,
Director, Specialty Pharmaceuticals
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-10-05
Posted date:
2022-10-12
Communication number:
371995-543118
View associated registration
-
Boehringer Ingelheim Canada Ltd.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Zachary Nixon,
Senior Assistant, Stakeholder Relations & Regional Affairs
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Health
Communication date:
2022-10-03
Posted date:
2022-10-12
Communication number:
371995-543110
View associated registration
